The present invention relates to compositions and methods relating to the characterization and function of V1a vasopressin receptor. Specifically, the present invention provides transgenic animals comprising disruptions in a V1a vasopressin receptor gene and methods of treating diseases conditions, such as schizophrenia, diabetes and inflammatory bowel disease. The present invention further relates to agents that modulate V1a vasopressin receptor and methods of screening for agents that modulate V1a vasopressin receptor for the treatment of diseases and conditions such as schizophrenia, diabetes and inflammatory bowel disease.

 
Web www.patentalert.com

< Prostaglandin compounds for the treatment of obesity

< Regulation of human serine-threonine protein kinase

> Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species

> Prion-free transgenic ungulates
~ 00265